TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 37863366

Group type: EXPERIMENTAL
Intervention: Specialist Depression Service (SDS) offering collaborative treatment with cognitive behavioural therapy (CBT) and pharmacotherapy for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SDS
Number of subjects: 0
Study: 34274620

Group type: EXPERIMENTAL
Intervention: Botulinum Neurotoxin (BoNT) treatment
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline ASR response
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline SSR response
Number of subjects: 14
Study: 36416367

Group type: EXPERIMENTAL
Intervention: Critical flicker-fusion frequency (CFF) measurement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Visual fatigue symptom scores
Number of subjects: 120
Study: 32996139

Group type: EXPERIMENTAL
Intervention: Antenatal exercise program including pelvic floor muscle training (12-week standardized program with once weekly group classes and twice weekly home sessions)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Standard antenatal care (control group)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Antenatal exercise program including pelvic floor muscle training
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 722
Study: 35305593

Group type: EXPERIMENTAL
Intervention: Lenvatinib plus PD-1 blockades
Number of subjects: 84
Study: 34608333

Group type: EXPERIMENTAL
Intervention: Talimogene laherparepvec (T-VEC) plus surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 150
Study: 33313725

Group type: EXPERIMENTAL
Intervention: BCBT‐CP with monthly telehealth booster contacts
Number of subjects: 716

Group type: COMPARATOR
Intervention: BCBT‐CP without booster contacts
Number of subjects: 716
Study: 34774360

Group type: EXPERIMENTAL
Intervention: High-dose (HD) vaccine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Adjuvanted (AD) vaccine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 160
Study: 33000586

Group type: EXPERIMENTAL
Intervention: Scalp-acupuncture plus standard care for 14 days (6 days/week)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Scalp-acupuncture plus standard care
Number of subjects: 120
Study: 35130043

Group type: EXPERIMENTAL
Intervention: Nurse‐WRITE
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: SD‐WRITE
Number of subjects: 497

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 497
Study: 32950939

Group type: EXPERIMENTAL
Intervention: Digital CBT (Daylight™)
Number of subjects: 21
Study: 32241795

Group type: EXPERIMENTAL
Intervention: COBRA Slim (methotrexate + step-down glucocorticoid)
Number of subjects: 379

Group type: COMPARATOR
Intervention: COBRA Classic (methotrexate + step-down glucocorticoid + sulphasalazine)
Number of subjects: 379

Group type: COMPARATOR
Intervention: COBRA Avant-Garde (methotrexate + step-down glucocorticoid + leflunomide)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Tight-Step-Up (MTX without GCs)
Number of subjects: 379
Study: 36159315

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) training (n = 11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional resistance training (Control Group, CG) (n = 9)
Number of subjects: 20
Study: 33295693

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline nebulization
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional ACT (200 µg of inhaled salbutamol only)
Number of subjects: 52
Study: 34748096

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 59
Study: 34162752

Group type: EXPERIMENTAL
Intervention: Vesatolimod
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32895247

Group type: EXPERIMENTAL
Intervention: CPAP + Prone Positioning (PP)
Number of subjects: 24
Study: 36050663

Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social Skills Training (HOPES/SST)
Number of subjects: 0
Study: 33503332

Group type: EXPERIMENTAL
Intervention: Left parietal lobe training (LPL group, n=13)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Right parietal lobe training (RPL group, n=13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both LPL and RPL groups
Number of subjects: 26
Study: 33220323

Group type: EXPERIMENTAL
Intervention: Tafamidis 80 mg
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Tafamidis 20 mg
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Pooled Tafamidis (80 mg and 20 mg)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study: 32616003

Group type: EXPERIMENTAL
Intervention: TightRope® (dynamic device)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3.5 mm metallic screw (static implant)
Number of subjects: 0
Study: 35612245

Group type: EXPERIMENTAL
Intervention: SP‐ECG
Number of subjects: 33

Group type: COMPARATOR
Intervention: C‐ECG
Number of subjects: 33
Study: 34105767

Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg every 8 weeks
Number of subjects: 1829

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 1829
Study: 36094537

Group type: EXPERIMENTAL
Intervention: Real-time prescription benefit recommendations
Number of subjects: 36419

Group type: COMPARATOR
Intervention: Control group (no RTPB recommendations)
Number of subjects: 36419
Study: 35220595

Group type: EXPERIMENTAL
Intervention: Copeland HHRI
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Global C.A.P. HHRI
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HHRIs with early offset-increasing migration pattern
Number of subjects: 32
Study: 34147791

Group type: EXPERIMENTAL
Intervention: Farmyard manure (FYM)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Slurry
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Methane fermentation digestion liquid (MFDL)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Mineral fertilizer only (Fert.)
Number of subjects: 3

Group type: COMPARATOR
Intervention: No-N control (Cont.)
Number of subjects: 3
Study: 32794125

Group type: EXPERIMENTAL
Intervention: 1000 ppm SeMet
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 2000 ppm SeMet
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 35587346

Group type: EXPERIMENTAL
Intervention: Face-to-face CPR training
Number of subjects: 320

Group type: COMPARATOR
Intervention: Virtual Reality CPR training
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 320
Study: 33640012

Group type: EXPERIMENTAL
Intervention: Megestrol (4-week course)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 32645234

Group type: EXPERIMENTAL
Intervention: Large volume transfusion (20 mL/kg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard volume transfusion (15 mL/kg)
Number of subjects: 39
Study: 36010894

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid mesh sheet (Neoveil™) applied after fibrin glue
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group with only fibrin glue
Number of subjects: 330
Study: 33402707

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (hypothermia arm from three RCTs)
Number of subjects: 280
Study: 35815754

Group type: EXPERIMENTAL
Intervention: Exclusion by straight men
Number of subjects: 194

Group type: COMPARATOR
Intervention: Inclusion by straight men
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Exclusion by gay men
Number of subjects: 194

Group type: COMPARATOR
Intervention: Inclusion by gay men
Number of subjects: 194
Study: 33606902

Group type: EXPERIMENTAL
Intervention: semaglutide
Number of subjects: 6480

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6480
Study: 32291291

Group type: EXPERIMENTAL
Intervention: Problem-solving intervention (PSI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 100
Study: 35838488

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other vasoconstrictors
Number of subjects: 0
Study: 32789503

Group type: EXPERIMENTAL
Intervention: HA-WBRT
Number of subjects: 65

Group type: COMPARATOR
Intervention: C-WBRT
Number of subjects: 65
Study: 35338577

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy intervention for renal fatigue
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 34413064

Group type: EXPERIMENTAL
Intervention: Immediate endovascular treatment
Number of subjects: 366

Group type: COMPARATOR
Intervention: No information regarding the patient's profession
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Participants older than 60 years
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Participants with more experience in neurointervention
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Participants who personally performed >100 endovascular treatments per year
Number of subjects: 366
Study: 32557302

Group type: EXPERIMENTAL
Intervention: Decentralized Clinical Trials (DCTs) recommendations
Number of subjects: 0
Study: 35795564

Group type: EXPERIMENTAL
Intervention: Oil Palm Phenolics (OPP) 250 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oil Palm Phenolics (OPP) 1000 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oil Palm Phenolics (OPP) 1500 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33917916

Group type: EXPERIMENTAL
Intervention: 6 week low-dose combined resistance and endurance training program (TG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study: 33053048

Group type: EXPERIMENTAL
Intervention: Forced air warming (FAW) with pre-warmed Ringer's solution
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group with Ringer's solution without FAW
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Forced air warming (FAW)
Number of subjects: 62
Study: 36423442

Group type: EXPERIMENTAL
Intervention: TAU plus up to 26 sessions of TwV therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 50
Study: 34543267

Group type: EXPERIMENTAL
Intervention: Patient-centered integrated chronic care model including treatment for hypertension, diabetes, and HIV.
Number of subjects: 10928

Group type: COMPARATOR
Intervention: Standard country-guided treatment (control group).
Number of subjects: 10928
Study: 36322925

Group type: EXPERIMENTAL
Intervention: Swaddling during bottle feeding
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unswaaddled during bottle feeding
Number of subjects: 30
Study: 35035312

Group type: EXPERIMENTAL
Intervention: Chinkuei Shin Chewan Decoction
Number of subjects: 110

Group type: COMPARATOR
Intervention: Traditional medicine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Artificial intelligence-based U-net registration algorithm
Number of subjects: 110
Study: 32652527

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36619724

Group type: EXPERIMENTAL
Intervention: HP eradication treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard NASH treatment
Number of subjects: 40
Study: 34728848

Group type: EXPERIMENTAL
Intervention: 2.0 mm Endo GIA stapler
Number of subjects: 16

Group type: COMPARATOR
Intervention: Suture ligation
Number of subjects: 16
Study: 32567544

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination sitagliptin and metformin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 60
Study: 35468325

Group type: EXPERIMENTAL
Intervention: Tirzepatide 10 mg and 15 mg
Number of subjects: 296

Group type: COMPARATOR
Intervention: Insulin degludec
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Tirzepatide groups
Number of subjects: 296
Study: 33481032

Group type: EXPERIMENTAL
Intervention: RCT-trained model applied to EHR data
Number of subjects: 2113

Group type: EXPERIMENTAL
Intervention: EHR-trained model
Number of subjects: 2113
Study: 32563025

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) from a single donor, administered three times with an interval of 2-3 months.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 16
Study: 36153518

Group type: EXPERIMENTAL
Intervention: Fruit and Vegetable Intervention Arm (weekly counseling and supplemental fruit and vegetable box delivery for 20 weeks)
Number of subjects: 400

Group type: COMPARATOR
Intervention: USDA MyPlate Control Arm (standard dietary guidance)
Number of subjects: 400
Study: 32376732

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BRJ) (12.9 mmol nitrate), consumed 3 hours prior to each PR session.
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo nitrate-deplete BRJ, consumed 3 hours prior to each PR session.
Number of subjects: 165
Study: 35581902

Group type: EXPERIMENTAL
Intervention: Low-dose lobeglitazone (0.25 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose lobeglitazone (0.5 mg/day)
Number of subjects: 0
Study: 34044810

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with sintilimab
Number of subjects: 163

Group type: COMPARATOR
Intervention: Induction chemotherapy only
Number of subjects: 163
Study: 32310197

Group type: EXPERIMENTAL
Intervention: Task-oriented circuit training (TOCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG) - relaxation exercises
Number of subjects: 20
Study: 34847841

Group type: EXPERIMENTAL
Intervention: FilmArray® Pneumonia Panel plus (FAP plus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine diagnostics (RT‐PCR and ID NOW™ Influenza A and B 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ID NOW™ Influenza A and B 2
Number of subjects: 0
Study: 33179399

Group type: EXPERIMENTAL
Intervention: Adjunctive focal site ablation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pulmonary vein isolation
Number of subjects: 80
Study: 35431027

Group type: EXPERIMENTAL
Intervention: U‐shaped tube embedded with radiopaque markers
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Anatomic tooth cusps
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bone markers with random number table method
Number of subjects: 11
Study: 34682394

Group type: EXPERIMENTAL
Intervention: Stage-tailored report back process
Number of subjects: 87
Study: 32885263

Group type: EXPERIMENTAL
Intervention: Standard withdrawal (≥6 or 8 minutes)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Segmental withdrawal (≥3 or ≥4 minutes dedicated to the right side, minimum withdrawal time of ≥6 or 8 minutes)
Number of subjects: 311
Study: 34231546

Group type: EXPERIMENTAL
Intervention: Home- or community-based exercise program with formal instruction and health care provider involvement
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Home- or community-based exercise program
Number of subjects: 15
Study: 32445718

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 963829

Group type: COMPARATOR
Intervention: Control
Number of subjects: 963829
Study: 35089153

Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioral therapy (iCBT) for 5 weeks
Number of subjects: 109

Group type: COMPARATOR
Intervention: psychoeducation for 5 weeks
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioral therapy (iCBT)
Number of subjects: 109

Group type: COMPARATOR
Intervention: psychoeducation
Number of subjects: 109
Study: 33723721

Group type: EXPERIMENTAL
Intervention: TensioBot (chatbot assistant)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no chatbot)
Number of subjects: 112
Study: 33142448

Group type: EXPERIMENTAL
Intervention: Sodium bisulfate (SB)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Challenged control
Number of subjects: 1200
Study: 36028376

Group type: EXPERIMENTAL
Intervention: Dual plating (Group 1 and Group 3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lateral plating (Group 2 and Group 4)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dual plating (Group 3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lateral plating (Group 4)
Number of subjects: 20
Study: 33670474

Group type: EXPERIMENTAL
Intervention: Real-time visual feedback training (VFT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 26
Study: 35532064

Group type: EXPERIMENTAL
Intervention: Bright white light (10,000 lux) applied for 30 minutes every morning for 14 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Dim red light (<50 lux) applied for 30 minutes every morning for 14 days
Number of subjects: 52
Study: 34237697

Group type: EXPERIMENTAL
Intervention: Enhanced nutritional supplement
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard nutritional supplement
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both supplements
Number of subjects: 27
Study: 36118671

Group type: EXPERIMENTAL
Intervention: MDT continuous care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 90
Study: 33813906

Group type: EXPERIMENTAL
Intervention: New intervention
Number of subjects: 0
Study: 32120787

Group type: EXPERIMENTAL
Intervention: Combination of water-soluble coenzyme Q10 (Q10Vital®) and collagen
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 35038165

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham subcutaneous injection of normal saline
Number of subjects: 51
Study: 34127273

Group type: COMPARATOR
Intervention: Continued treatment with AChEI medications (sham-taper group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Treatment discontinuation via tapering (real-taper group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both treatment arms (sham-taper and real-taper)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Caregiver's mood
Number of subjects: 62
Study: 32872476

Group type: EXPERIMENTAL
Intervention: Patients with CDI recurrence (n=77)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (n=74)
Number of subjects: 151
Study: 36246996

Group type: EXPERIMENTAL
Intervention: Perioperative intravenous amiodarone infusion
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 33742159

Group type: EXPERIMENTAL
Intervention: Drinking Chinese green tea (GT group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Potable water (PW group)
Number of subjects: 80
Study: 33980309

Group type: EXPERIMENTAL
Intervention: Surgery (intervention group)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 63
Study: 32386761

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1209

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 1209
Study: 34404828

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 27
Study: 32453383

Group type: EXPERIMENTAL
Intervention: Academic detailing
Number of subjects: 5363

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5363
Study: 35245262

Group type: EXPERIMENTAL
Intervention: Caregiver educational program consisting of eight sessions (three educational sessions on COPD, two on coping strategies, three peer support sessions).
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Caregiver educational program.
Number of subjects: 92
Study: 34184991

Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioral therapy
Number of subjects: 45
Study: 32886421

Group type: EXPERIMENTAL
Intervention: Geriatric interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 33710942

Group type: EXPERIMENTAL
Intervention: Enhanced active choice invitation letter
Number of subjects: 8349

Group type: COMPARATOR
Intervention: Standard opt-in invitation letter (control condition)
Number of subjects: 8349
Study: 32889703

Group type: EXPERIMENTAL
Intervention: ACDC intervention (14-week CBT-based group course)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Usual Care (UC) control condition
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: ACDC intervention
Number of subjects: 228
Study: 34546226

Group type: EXPERIMENTAL
Intervention: 2D digital photography
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bellus3D
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 3D facial scanners
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intraoral scans
Number of subjects: 15
Study: 34600123

Group type: EXPERIMENTAL
Intervention: Surgery (total knee replacement)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Preoperative PTSD symptoms
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Medical claims filed before surgery
Number of subjects: 207
Study: 33054695

Group type: EXPERIMENTAL
Intervention: Overnight fasting
Number of subjects: 21

Group type: COMPARATOR
Intervention: Breakfast containing 20% of the total recommended daily calories
Number of subjects: 21
Study: 34293304

Group type: EXPERIMENTAL
Intervention: Semaglutide 2·0 mg
Number of subjects: 961

Group type: COMPARATOR
Intervention: Semaglutide 1·0 mg
Number of subjects: 961
Study: 32727618

Group type: EXPERIMENTAL
Intervention: Integrated Stepped Alcohol Treatment (ISAT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 93
Study: 33170353

Group type: EXPERIMENTAL
Intervention: 3D printed models of plates applied to the humerus
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Three different plates applied to the 3D models
Number of subjects: 120
Study: 33765335

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamycin (GO) 6 mg/m2 added to standard chemotherapy
Number of subjects: 254

Group type: COMPARATOR
Intervention: Standard chemotherapy alone
Number of subjects: 254